A New Drug May Stimulate the Immune System to Attack Pancreatic Cancer
Researchers are conducting a phase 0 study of a new drug that may cause inflammation to stimulate immune system against cancer.
Gut Reaction for Pancreatic Cancer
Dr. Florencia McAllister and her team are looking at the tumor microbiome to develop effective pancreatic cancer treatments.
AACR Annual Meeting 2021 Highlights
Let’s Win and the Lustgarten Foundation bring you the pancreatic cancer research highlights of the 2021 AACR Annual Meeting,
Cachexia Research Gaining Momentum
Why do pancreatic cancer patients lose weight even if they are eating well? Dr. Teresa Zimmers explains the syndrome called cachexia.
Testing a Drug that Works Only in the Tumor Microenvironment
Scientists are trying a new type of drug combination that gets activated only in the unique conditions of the tumor microenvironment.
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
New Research Sheds Light on Hot and Cold Tumors
Dr. Ben Z. Stanger and his team are finding links between the number of T cells a tumor has and the effectiveness of immunotherapy.
Stand Up To Cancer Announces $11M Collaborative, Multidisciplinary Research Program; Microsoft Will Bring Power of AI to Investigate Immune System Response to Cancers
Stand Up To Cancer launches a multidisciplinary collaborative research program with Microsoft Research using artificial intelligence.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
Targeted Therapy for Pancreatic Cancer
Dr. Margaret Tempero outlines the work being done in the area of targeted therapy for pancreatic cancer, specifically the testing of ibrutinib.